Brain Cancer Canada Awards
CAD 100,000 grant for enhanced
patient-specific
drug delivery in DIPG.

Brain Cancer Canada (BCC) has just matched the incredible $50,000 raised by the relentless DIPG community, bringing the total to a extraordinary $100,000! This grant is awarded to the brilliant Dr. James T. Rutka, Paediatric Neurosurgeon at SickKids, and his team, pioneering a novel approach to combat Diffuse Intrinsic Pontine Glioma (DIPG), a disease without effective treatments.

“The primary aim of our research is to explore innovative methods to deliver therapeutics more effectively to DIPGs,” Dr. Rutka said. “We are excited that our encouraging pre-clinical studies on DIPG have now been translated into the ‘first in human’ clinical trial for children with this otherwise fatal brainstem tumour. By combining MRgFUS with patient-specific biologicals, we hope to increase the concentration of active compounds within this brain-stem tumour, potentially influencing tumour growth and survival.”

Click for official press release:
https://www.globenewswire.com/news-release/2023/05/17/2671067/0/en/Brain-Cancer-Canada-Matches-Community-Fundraising-to-Support-Groundbreaking-DIPG-Research.html